PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.31%
Negative revenue growth while QRVO stands at 4.10%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.07%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-8.06%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-9.04%
Negative operating income growth while QRVO is at 39.52%. Joel Greenblatt would press for urgent turnaround measures.
-1.78%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
No Data
No Data available this quarter, please select a different quarter.
-0.79%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.47%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.44%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.16%
Dividend reduction while QRVO stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-48.39%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-53.02%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
133.94%
10Y revenue/share CAGR above 1.5x QRVO's 32.13%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
38.70%
5Y revenue/share CAGR 1.25-1.5x QRVO's 32.13%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
28.08%
3Y revenue/share CAGR 1.25-1.5x QRVO's 22.34%. Bruce Berkowitz might see better product or regional expansions than the competitor.
498.85%
10Y OCF/share CAGR in line with QRVO's 480.74%. Walter Schloss would see both as similarly efficient over the decade.
175.85%
Below 50% of QRVO's 480.74%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
116.94%
Positive 3Y OCF/share CAGR while QRVO is negative. John Neff might see a big short-term edge in operational efficiency.
9620.45%
Positive 10Y CAGR while QRVO is negative. John Neff might see a substantial advantage in bottom-line trajectory.
187.69%
Positive 5Y CAGR while QRVO is negative. John Neff might view this as a strong mid-term relative advantage.
83.48%
Positive short-term CAGR while QRVO is negative. John Neff would see a clear advantage in near-term profit trajectory.
25.60%
Below 50% of QRVO's 303.17%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-7.65%
Negative 5Y equity/share growth while QRVO is at 303.17%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-6.64%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
597.21%
Dividend/share CAGR of 597.21% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
156.46%
Dividend/share CAGR of 156.46% while QRVO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
102.64%
3Y dividend/share CAGR of 102.64% while QRVO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
19.30%
AR growth well above QRVO's 19.86%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.88%
Inventory is declining while QRVO stands at 6.20%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.79%
Positive asset growth while QRVO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-3.87%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
21.41%
We have some new debt while QRVO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-2.75%
Our R&D shrinks while QRVO invests at 0.10%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
No Data
No Data available this quarter, please select a different quarter.